000 01437 a2200409 4500
005 20250518083557.0
264 0 _c20210517
008 202105s 0 0 eng d
022 _a1879-0844
024 7 _a10.1002/ejhf.1749
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aStöhr, Robert
245 0 0 _aLimited role for fibroblast growth factor 23 in assessing prognosis in heart failure patients: data from the TIME-CHF trial.
_h[electronic resource]
260 _bEuropean journal of heart failure
_c04 2020
300 _a701-709 p.
_bdigital
500 _aPublication Type: Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
650 0 4 _aAged
650 0 4 _aFibroblast Growth Factor-23
650 0 4 _aFibroblast Growth Factors
_xanalysis
650 0 4 _aHeart Failure
650 0 4 _aHumans
650 0 4 _aMiddle Aged
650 0 4 _aPrognosis
650 0 4 _aStroke Volume
650 0 4 _aVentricular Function, Left
700 1 _aBrandenburg, Vincent M
700 1 _aHeine, Gunnar H
700 1 _aMaeder, Micha T
700 1 _aLeibundgut, Gregor
700 1 _aSchuh, Alexander
700 1 _aJeker, Urs
700 1 _aPfisterer, Matthias
700 1 _aSanders-van Wijk, Sandra
700 1 _aBrunner-la Rocca, Hans-Peter
773 0 _tEuropean journal of heart failure
_gvol. 22
_gno. 4
_gp. 701-709
856 4 0 _uhttps://doi.org/10.1002/ejhf.1749
_zAvailable from publisher's website
999 _c30597899
_d30597899